Search results for "prospective"

showing 10 items of 3738 documents

Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry

2022

Skin and soft tissue infections (SSTIs) represent a heterogenous group of pathological conditions involving the skin or the underlying subcutaneous tissues, fascia and muscle, characterised by a considerable variety of clinical presentations, severity and possible aetiological pathogens. Although previous analyses on restricted types of SSTIs and population have already been published, we conducted a large nationwide surveillance program on behalf of the Italian Society of Infectious and Tropical Diseases to assess the clinical and microbiological characteristics of the whole SSTI spectrum, from mild to severe life-threatening infections, in both inpatients and outpatients and their managem…

PharmacologyAdultRegistrieSoft Tissue InfectionsSoft Tissue Infections.SSTIComorbidityABSSSIregistryABSSSIs; SSTIs; registryABSSSIsAnti-Bacterial AgentsProspective StudieInfectious DiseasesOncologySSTIsItalyAnti-Bacterial AgentHumansPharmacology (medical)Prospective StudiesRegistriesHuman
researchProduct

Comparison of a 48-Hour Infusion of 5-Fluorouracil without Folinic Acid with 24-Hour Folinic Acid/5-Fluorouracil in Patients with Metastatic Colorect…

2003

<i>Background:</i> Out of various high-dose 5-fluorouracil (5-FU) regimens given with or without folinic acid (FA), the optimal 5-FU schedule has still to be defined as treatment for metastatic colorectal cancer (CRC). Consequently, we compared toxicity, response and survival following two FA/5-FU regimens in 55 CRC patients refractory to bolus FA/5-FU. <i>Methods:</i> Twenty-eight patients (group A) received 5-FU (60 mg/kg body weight) for 48 h, and 27 (group B) received 2-hour infusions of FA (500 mg/m<sup>2</sup>) and 24-hour infusions of 5-FU (2,600 mg/m<sup>2</sup>) until disease progression. <i>Results:</i> Both groups were a…

PharmacologyChemotherapymedicine.medical_specialtymedicine.drug_classbusiness.industryColorectal cancermedicine.medical_treatmentSalvage therapyGeneral Medicinemedicine.diseaseAntimetaboliteGastroenterologySurgeryFolinic acidInfectious DiseasesBolus (medicine)OncologyFluorouracilInternal medicineDrug DiscoverymedicinePharmacology (medical)Prospective cohort studybusinessmedicine.drugChemotherapy
researchProduct

Evaluación de la calidad de dos modelos de atención farmacéutica en pacientes onco-hematológicos

2007

Objective: To compare the quality of two pharmaceutical care models (with and without pharmacist participation in the clinical team), in hospitalised onco-haematological patients. Method: A prospective cohort study in the oncology and haematology departments of a university hospital over a 26-month period. A centralised model (model C) was used over 16 months and a decentralised integration model (model D) was used during the remaining 10 months. The Iaser© methodology was used to identify candidates for improved drug treatment and for the follow up of patients with drug-related problems (DRP). The results obtained were compared using a series of pharmaceutical care quality indicators. Resu…

PharmacologyClinical teammedicine.medical_specialtybusiness.industryPsychological interventionPharmacistUniversity hospitalSurgeryPharmaceutical careInternal medicinemedicineInterprofessional teamworkIn patientProspective cohort studybusinessFarmacia Hospitalaria
researchProduct

A prospective study of adverse drug reactions in hospitalized children

1999

Aims There are few publications of adverse drug reactions (ADRs) among paediatric patients, though ADR incidence is usually stated to be higher during the first year of life and in male patients. We have carried out a prospective study to assess the extent, pattern and profile risk for ADRs in hospitalized patients between 1 and 24 months of age. Methods An intensive events monitoring scheme was used. A total of 512 successive admissions to two medical paediatric wards (47 beds) were analysed. The hospital records were screened daily during two periods (summer, 105 days and winter, 99 days), and adverse clinical events observed were recorded. Results A total of 282 events were detected; of …

PharmacologyDrugPediatricsmedicine.medical_specialtybusiness.industrymedia_common.quotation_subjectIncidence (epidemiology)El NiñomedicinePharmacology (medical)Cumulative incidenceDrug reactionRisk factorbusinessProspective cohort studymedia_commonPaediatric patientsBritish Journal of Clinical Pharmacology
researchProduct

2015

BACKGROUND Expensive pharmaceuticals are a major reason for cost intensive health care systems. Long-term immunosuppressive therapy plays a relevant role after organ transplantation. Patents of original drugs have expired and cheaper products are available. Little data are available regarding efficacy and safety of generic immunosuppressive agents. METHODS In this prospective study, 25 patients, who were clinically stable for a minimum of 2 years after liver transplantation, were converted from the original formulations of tacrolimus (TAC) and mycophenolate mofetil to the generics Tacpan (TAP) and Mowel (MOW). Patients were followed-up for 6 months. Results were compared retrospectively to …

PharmacologyPathologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentPharmaceutical ScienceImmunosuppressionLiver transplantationMycophenolateTacrolimusMycophenolic acidOrgan transplantationInternal medicineDrug DiscoverymedicineTrough levelProspective cohort studybusinessmedicine.drugDrug Design, Development and Therapy
researchProduct

Monitorización de la vacomicina en administración intraperitoneal en pacientes sometidos a diálisis peritoneal continua ambulatoria

2012

Objective: To validate a pharmacokinetic model of the treatments with intraperitoneal vancomycin applied to patients on continuous ambulatory peritoneal dialysis with bacterial peritonitis. Methods: To carry out a prospective study divided in 2 cohorts: the first one including ten patients of 56 ± 14 years and 65 ± 5 kg, and the second one with 10 patients (12 episodes of peritonitis) aged 52 ± 13 years and 64 ± 8 kg. The treatment consists of administering and retaining for 6 h in the peritoneal cavity a solution containing 2 g of vancomycin and 1 g of ceftazidime into 2 l of ‘‘dialysis solution’’. After the antibiotic administration, blood samples were obtained at 4, 6, 8, 10, 24, 48 and …

Pharmacologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentContinuous ambulatory peritoneal dialysisUrologyPeritonitismedicine.diseasePeritoneal dialysisPharmacokineticsCohortmedicineVancomycinProspective cohort studybusinessmedicine.drugCohort studyFarmacia Hospitalaria
researchProduct

Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia

2015

Summary. Introduction. Sorafenib, an oral multikinase inhibitor, is the only targeted agent approved for the treatment of patients with hepatocellular carcinoma (HCC) after demonstration to increase overall survival compared to placebo in two randomized phase III study. GIDEON (Global Investigation of therapeutic DEcisions in HCC and Of its treatment with sorafeNib) is the largest, global, non-interventional, prospective study of patients with uHCC (n>3200) treated with sorafenib in real-life clinical practice conditions. Here we report the final analysis of safety and efficacy in the Italian cohort of patients. Methods. Patients with unresectable HCC who are candidates for systemic ther…

Phenylurea CompoundAdultMaleNiacinamideCarcinoma HepatocellularHepatocellular carcinomaAntineoplastic AgentsAntineoplastic Agent80 and overHumansProspective StudiesAgedAged 80 and overGIDEON study; Hepatocellular carcinoma; Sorafenib; Adult; Aged; Aged 80 and over; Antineoplastic Agents; Carcinoma Hepatocellular; Female; Humans; Italy; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Prospective Studies; Medicine (all)Phenylurea CompoundsMedicine (all)CarcinomaLiver NeoplasmsHepatocellularSorafenibMiddle AgedProspective StudieHepatocellular carcinoma sorafenib GIDEON studyItalyLiver NeoplasmFemaleHumanGIDEON study
researchProduct

Predicting ACL Injury Using Machine Learning on Data From an Extensive Screening Test Battery of 880 Female Elite Athletes

2022

Background: Injury risk prediction is an emerging field in which more research is needed to recognize the best practices for accurate injury risk assessment. Important issues related to predictive machine learning need to be considered, for example, to avoid overinterpreting the observed prediction performance. Purpose: To carefully investigate the predictive potential of multiple predictive machine learning methods on a large set of risk factor data for anterior cruciate ligament (ACL) injury; the proposed approach takes into account the effect of chance and random variations in prediction performance. Study Design: Case-control study; Level of evidence, 3. Methods: The authors used 3-dime…

Physical Therapy Sports Therapy and Rehabilitationcross-validationMachine LearningurheiluHumansprediction significanceOrthopedics and Sports MedicinejoukkueurheiluProspective StudiesliikeanalyysisuorituskykyurheiluvammatACL injuryAnterior Cruciate Ligament Injuriesmotion analysispredictive methodsmachine learningkoneoppiminenAthletesCase-Control StudiesAthletic InjuriesennustettavuusFemaleteam sportsloukkaantuminen (fyysinen)urheilijat
researchProduct

DNA methylation changes associated with prenatal mercury exposure:A meta-analysis of prospective cohort studies from PACE consortium

2022

Mercury (Hg) is a ubiquitous heavy metal that originates from both natural and anthropogenic sources and is transformed in the environment to its most toxicant form, methylmercury (MeHg). Recent studies suggest that MeHg exposure can alter epigenetic modifications during embryogenesis. In this study, we examined associations between prenatal MeHg exposure and levels of cord blood DNA methylation (DNAm) by meta-analysis in up to seven independent studies (n = 1462) as well as persistence of those relationships in blood from 7 to 8 year-old children (n = 794). In cord blood, we found limited evidence of differential DNAm at cg24184221 in MED31 (β = 2.28 × 10-4, p-value = 5.87 × 10-5) in relat…

PhysiologyBiochemistrychemistry.chemical_compoundPregnancyPrenatal exposureMedicineHumansEpigeneticsProspective StudiesProspective cohort studyChildMethylmercuryGeneral Environmental ScienceMediator ComplexDNA methylationbusiness.industrydNaMMethylmercuryMercuryMethylmercury CompoundsPACEALSPACFetal BloodchemistryCord bloodMeta-analysisChild PreschoolPrenatal Exposure Delayed EffectsDNA methylationFemaleHELIX studybusinessToxicant
researchProduct

Effects of the prolonged thoracic epidural analgesia on ventilation function and complication rate after the lung cancer surgery.

2006

Thoracic epidural analgesia has been considered to have a good anesthetic efficacy and to decrease the postoperative complication rate, while its effect upon the ventilation function is still the topic of many clinical studies. The aim of this study was to evaluate the course of early postoperative period using thoracic epidural analgesia. Material and methods. A total of 453 patients undergoing the operation due to the non–small cell carcinoma were selected and examined. Their postoperative complications and mortality rate were evaluated. In 79 patients, arterial oxygen saturation (SaO2), forced vital capacity, forced expiratory volume in the first second, and the efficacy of analgesia wer…

Plaučiai--Komp¬likacijosVital capacitymedicine.medical_specialtyLung NeoplasmsTime Factorsmedicine.medical_treatmentVital CapacityAnesthesia GeneralLungs--SurgeryPneumonectomyPostoperative Complicationsthoracic epidural analgesiaCarcinoma Non-Small-Cell LungForced Expiratory VolumemedicineHumansProspective StudiesProspective cohort studyPneumonectomyLungs--ComplicationsPain MeasurementLung cancer surgeryPain Postoperativebusiness.industryMortality rateIncidencePostoperative complicationlung functionGeneral MedicineSurgerylung surgery; thoracic epidural analgesia; lung function; postoperative complicationsAnalgesia Epidurallung surgeryAnesthesiaData Interpretation StatisticalAnestheticBreathingPlaučiai--ChirurgijabusinessPulmonary Ventilationmedicine.drugMedicina (Kaunas, Lithuania)
researchProduct